Abstract
Smoking and exposure to secondhand smoke are the most important preventable risk factors that contribute to premature death from coronary heart disease (CHD). The US adult smoking prevalence rates decreased from 24% in 1998 to 21% in 2008 (Dube, Asman, Malarcher, & Carabollo, 2009), but during the past 5 years, smoking rates have not changed. Men are more likely to smoke than women, and American Indians/Alaska Natives have the highest smoking rate of all ethnicities. Smoking is more prevalent in adults with low educational attainment and in those from lower socioeconomic strata. Clinicians should offer and provide effective smoking cessation interventions to reduce these numbers in developing countries, especially in subpopulations which can obtain maximum benefits from quitting smoking.
Keywords
- Smoking Cessation
- Withdrawal Symptom
- Nicotine Replacement Therapy
- Nicotine Patch
- Smoking Cessation Intervention
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Al Rashidi, M., Shihadeh, A., & Saliba, N. (2008). Volatile aldehydes in the mainstream smoke of the narghile waterpipe. Food and Chemical Toxicology, 46(11), 3546–3549.
American Cancer Society. (2009). Questions about smoking, tobacco, and health. Retrieved from http://www.cancer.org/docroot/PED/content/PED_10_2x_Questions_About_Smoking_Tobacco_and_Health.asp.
American Heart Association. (2002). An active partnership for the health of your heart. Dallas: American Heart Association.
American Lung Association. (2007). An emerging deadly trend: Waterpipe tobacco use. Retrieved from http://slati.lungusa.org/alerts/Trend%20Alert_Waterpipes.pdf.
American Psychiatric Association. (2000). Diagnositic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
An, L. C., Foldes, S. S., Alesci, N. L., Bluhm, J. H., Bland, P. C., Davern, M. E., et al. (2008). The impact of smoking-cessation intervention by multiple health professionals. American Journal of Preventive Medicine, 34(1), 54–60.
Aubin, H. J. (2002). Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs, 62(Suppl 2), 45–52.
Baile, W. F., Jr., Bigelow, G. E., Gottlieb, S. H., Stitzer, M. L., & Sacktor, J. D. (1982). Rapid resumption of cigarette smoking following myocardial infarction: Inverse relation to MI severity. Addictive Behaviors, 7(4), 373–380.
Barth, J., Critchley, J., & Bengel, J. (2008). Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane Database of Systematic Reviews (1), CD006886.
Benowitz, N. L. (1988). Pharmacologic aspects of cigarette smoking and nicotine addiction. The New England Journal of Medicine, 319, 1318–1330.
Benowitz, N. L., & Gourlay, S. G. (1997). Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. Journal of the American College of Cardiology, 29, 1422–1431.
Benowitz, N. L., Hall, S. M., Herning, R. I., Jacob, P. I., Jones, R. T., & Osman, A. L. (1983). Smokers of low-yield cigarettes do not consume less nicotine. The New England Journal of Medicine, 309(3), 139–142.
Benowitz, N. L., Jacob, P. I., Kozlowski, L., & Yu, L. (1986). Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. The New England Journal of Medicine, 315(21), 1310–1313.
Benowitz, N. L., & Samet, J. M. (2011). The threat of menthol cigarettes to U.S. public health. New England Journal of Medicine. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21542737. doi:10.1056/NEJMp1103610.
Bialous, S. A., Sarna, L., Wewers, M. E., Froelicher, E. S., & Danao, L. (2004). Nurses’ perspectives of smoking initiation, addiction, and cessation. Nursing Research, 53(6), 387–395.
Borrelli, B., Spring, B., Niaura, R., Hitsman, B., & Papandonatos, G. (2001). Influences of gender and weight gain on short-term relapse to smoking in a cessation trial. Journal of Consulting and Clinical Psychology, 69(3), 511–515.
Burt, A., Thornley, P., Illingworth, D., White, P., Shaw, T. R., & Turner, R. (1974). Stopping smoking after myocardial infarction. Lancet, 1(7852), 304–306.
Centers for Disease Control and Prevention. (1993). Physician and other health-care professional counseling of smokers to quit–United States, 1991. MMWR: Morbidity Mortal Weekly Report, 42(44), 854–857.
Cinciripini, P. M., Wetter, D. W., Fouladi, R. T., Blalock, J. A., Carter, B. L., Cinciripini, L. G., et al. (2003). The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. Journal of Consulting and Clinical Psychology, 71(2), 292–301.
Condiotte, M. M., & Lichtenstein, E. (1981). Self-efficacy and relapse in smoking cessation programs. Journal of Consulting and Clinical Psychology, 49(5), 648–658.
Crouse, J. R., III, & Hagaman, A. P. (1991). Smoking cessation in relation to cardiac procedures. American Journal of Epidemiology, 134(7), 699–703.
Dube, S. R., Asman, K., Malarcher, A., & Carabollo, R. (2009). Cigarette smoking among adults and trends in smoking cessation – United States, 2008. MMWR: Morbidity Mortal Weekly Report, 58(44), 1227–1232.
Durcan, M. J., Deener, G., White, J., Johnston, J. A., Gonzales, D., Niaura, R., et al. (2002). The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics, 24(4), 540–551.
Eissenberg, T., & Shihadeh, A. (2009). Waterpipe tobacco and cigarette smoking direct comparison of toxicant exposure. American Journal of Preventive Medicine, 37(9), 518–523.
El-Setouhy, M., Loffredo, C. A., Radwan, G., Abdel Rahman, R., Mahfouz, E., Israel, E., et al. (2008). Genotoxic effects of waterpipe smoking on the buccal mucosa cells. Mutation Research, 655(1–2), 36–40.
Emmons, K. M., & Goldstein, M. G. (1992). Smokers who are hospitalized: A window of opportunity for cessation interventions. Preventive Medicine, 21(2), 262–269.
Emmons, K. M., Goldstein, M. G., Roberts, M., Cargill, B., Sherman, C. B., Millman, R., et al. (2000). The use of nicotine replacement therapy during hospitalization. Annals of Behavioral Medicine, 22(4), 325–329.
Etter, J. F. (2005). A self-administered questionnaire to measure cigarette withdrawal symptoms: The cigarette withdrawal scale. Nicotine & Tobacco Research, 7(1), 47–57.
Fagerstroem, K. O. (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors, 3(3–4), 235–241.
Fagerstrom, K. O., & Schneider, N. G. (1989). Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine, 12(2), 159–182.
Freedman, R. (2007). Exacerbation of schizophrenia by varenicline. The American Journal of Psychiatry, 164(8), 1269.
Froelicher, E. S., Christopherson, D. J., Miller, N. H., & Martin, K. (2002). Women’s initiative for nonsmoking (WINS) IV: Description of 277 women smokers hospitalized with cardiovascular disease. Heart & Lung, 31(1), 3–14.
Froelicher, E. S., Doolan, D., Yerger, V. B., McGruder, C. O., & Malone, R. E. (2010). Combining community participatory research with a randomized clinical trial: The Protecting the Hood Against Tobacco (PHAT) smoking cessation study. Heart & Lung, 39(1), 50–63.
Ginn, M. B., Cox, G., & Heath, J. (2008). Evidence-based approach to an inpatient tobacco cessation protocol. AACN Advanced Critical Care, 19(3), 268–278.
Glasgow, R. E., Stevens, V. J., Vogt, T. M., Mullooly, J. P., & Lichtenstein, E. (1991). Changes in smoking associated with hospitalization: Quit rates, predictive variables, and intervention implications. American Journal of Health Promotion, 6(1), 24–29.
Glassman, A. H., Covey, L. S., Stetner, F., & Rivelli, S. (2001). Smoking cessation and the course of major depression: A follow-up study. Lancet, 357(9272), 1929–1932.
GlaxoSmithKline. (2003). Zyban prescribing information. Retrieved from http://us.gsk.com/products/assets/us_zyban.pdf.
Gritz, E. R., Nielsen, I. R., & Brooks, L. A. (1996). Smoking cessation and gender: The influence of physiological, psychological, and behavioral factors. Journal of the American Medical Women’s Association, 51(1–2), 35–42.
Gritz, E. R., Thompson, B., Emmons, K., Ockene, J. K., McLerran, D. F., & Nielsen, I. R. (1998). Gender differences among smokers and quitters in the working well trial. Preventive Medicine, 27(4), 553–561.
Grunberg, N. E. (1982). The effects of nicotine and cigarette smoking on food consumption and taste preferences. Addictive Behaviors, 7(4), 317–331.
Hall, S. M., Ginsberg, D., & Jones, R. T. (1986). Smoking cessation and weight gain. Journal of Consulting and Clinical Psychology, 54(3), 342–346.
Haukkala, A., Uutela, A., Vartiainen, E., McAlister, A., & Knekt, P. (2006). Depression and smoking cessation: The role of motivation and self-efficacy. Addictive Behaviors, 25(2), 311–316.
Haustein, K. O. (2003). Bupropion: Pharmacological and clinical profile in smoking cessation. International Journal of Clinical Pharmacology and Therapeutics, 41(2), 56–66.
Havik, O. E., & Maeland, J. G. (1988). Changes in smoking behavior after a myocardial infarction. Health Psychology, 7(5), 403–420.
Hays, J. T., & Ebbert, J. O. (2003). Bupropion for the treatment of tobacco dependence: Guidelines for balancing risks and benefits. CNS Drugs, 17(2), 71–83.
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86(9), 1119–1127.
Hermanson, B., Omenn, G. S., Kronmal, R. A., & Gersh, B. J. (1988). Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. The New England Journal of Medicine, 319(21), 1365–1369.
Holm, K. J., & Spencer, C. M. (2000). Bupropion: A review of its use in the management of smoking cessation. Drugs, 59(4), 1007–1024.
Hughes, J., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289–294.
Hurt, R. D., Dale, L. C., Croghan, G. A., Croghan, I. T., Gomez-Dahl, L. C., & Offord, K. P. (1998). Nicotine nasal spray for smoking cessation: Pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Mayo Clinic Proceedings, 73(2), 118–125.
Hutchinson, K. M., & Froelicher, E. A. (2003). Populations at risk for tobacco-related diseases. Seminars in Oncology Nursing, 19(4), 276–283.
Jabbour, S., El-Roueiheb, Z., & Sibai, A. (2003). Narghile (water-pipe) smoking and incident coronary heart disease: A case–control study. Annals of Epidemiology, 13(8), p570.
Jimenez-Ruiz, C., Berlin, I., & Hering, T. (2009). Varenicline: A novel pharmacotherapy for smoking cessation. Drugs, 69(10), 1319–1338.
Knishkowy, B., & Amitai, Y. (2005). Water-pipe (narghile) smoking: An emerging health risk behavior. Pediatrics, 116(1), e113–e119.
Kohen, I., & Kremen, N. (2007). Varenicline-induced manic episode in a patient with bipolar disorder. The American Journal of Psychiatry, 164(8), 1269–1270.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.
Krumholz, H. M., Cohen, B. J., Tsevat, J., Pasternak, R. C., & Weinstein, M. C. (1993). Cost-effectiveness of a smoking cessation program after myocardial infarction. Journal of the American College of Cardiology, 22(6), 1697–1702.
Lawrence, D., Graber, J. E., Mills, S. L., Meissner, H. I., & Warnecke, R. (2003). Smoking cessation interventions in U.S. racial/ethnic minority populations: An assessment of the literature. Preventive Medicine, 36(2), 204–216.
Lichtman, J. H., Bigger, J. T., Jr., Blumenthal, J. A., Frasure-Smith, N., Kaufmann, P. G., Lesperance, F., et al. (2008). Depression and coronary heart disease: Recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation, 118(17), 1768–1775.
Lyon, L. (2008). The rising allure-and danger-of hookah. US News. Retrieved from http://health.usnews.com/articles/health/2008/01/02/the-rising-allure--and-danger--of-hookah.html.
Mahrer-Imhof, R., Froelicher, E. S., Li, W. W., Parker, K. M., & Benowitz, N. L. (2002). Women’s initiative for nonsmoking (WINS V): Under-use of nicotine replacement therapy. Heart & Lung, 31(5), 368–373.
Marlatt, A. G. (1982). Relapse prevention: A self control program for the treatment of addictive behaviors. In R. B. Stuart (Ed.), Adherence, compliance and generalization in behavioral medicine (pp. 329–378). New York: Brunnel/Mazel.
Maziak, W. (2008). The waterpipe: Time for action. Addiction, 103(11), 1763–1767.
Maziak, W., Eissenberg, T., Rastam, S., Hammal, F., Asfar, T., Bachir, M. E., et al. (2004). Beliefs and attitudes related to narghile (waterpipe) smoking among university students in Syria. Annals of Epidemiology, 14(9), 646–654.
McCullough, A., Fisher, M., Goldstein, A. O., Kramer, K. D., & Ripley-Moffitt, C. (2009). Smoking as a vital sign: Prompts to ask and assess increase cessation counseling. Journal of the American Board of Family Medicine, 22(6), 625–632.
Miller, N. H., Smith, P. M., DeBusk, R. F., Sobel, D. S., & Taylor, C. B. (1997). Smoking cessation in hospitalized patients. Results of a randomized trial. Archives of Internal Medicine, 157(4), 409–415.
Mulcahy, R. (1983). Influence of cigarette smoking on morbidity and mortality after myocardial infarction. British Heart Journal, 49(5), 410–415.
Neergaard, J., Singh, P., Job, J., & Montgomery, S. (2007). Waterpipe smoking and nicotine exposure: A review of the current evidence. Nicotine & Tobacco Research, 9(10), 987–994.
O’Hara, P., Portser, S. A., & Anderson, B. P. (1989). The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addictive Behaviors, 14(6), 595–600.
Ockene, J. K., Emmons, K. M., Mermelstein, R. J., Perkins, K. A., Bonollo, D. S., Voorhees, C. C., et al. (2000). Relapse and maintenance issues for smoking cessation. Health Psychology, 19(1 Suppl), 17–31.
Ockene, J. K., Hosmer, D., Rippe, J., Williams, J., Goldberg, R. J., DeCosimo, D., et al. (1985). Factors affecting cigarette smoking status in patients with ischemic heart disease. Journal of Chronic Diseases, 38(12), 985–994.
Ockene, J. K., Kristeller, J. L., Goldberg, R., Ockene, I., Merriam, P., Barrett, S., et al. (1992). Smoking cessation and severity of disease: The Coronary Artery Smoking Intervention Study. Health Psychology, 11(2), 119–126.
Oncken, C., Gonzales, D., Nides, M., Rennard, S., Watsky, E., Billing, C. B., et al. (2006). Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Archives of Internal Medicine, 166(15), 1571–1577.
Pomerleau, C. S., Brouwer, R. J., & Pomerleau, O. F. (2001). Emergence of depression during early abstinence in depressed and non-depressed women smokers. Journal of Addictive Diseases, 20(1), 73–80.
Pomerleau, C. S., Zucker, A. N., & Stewart, A. J. (2001). Characterizing concerns about post-cessation weight gain: Results from a national survey of women smokers. Nicotine & Tobacco Research, 3(1), 51–60.
Primack, B. A., Sidani, J., Agarwal, A. A., Shadel, W. G., Donny, E. C., & Eissenberg, T. E. (2008). Prevalence of and associations with waterpipe tobacco smoking among U.S. university students. Annals of Behavioral Medicine, 36(1), 81–86.
Rice, V. H., Fox, D. H., Lepczyk, M., Sieggreen, M., Mullin, M., Jarosz, P., et al. (1994). A comparison of nursing interventions for smoking cessation in adults with cardiovascular health problems. Heart & Lung, 23(6), 473–486.
Rigotti, N. A., McKool, K. M., & Shiffman, S. (1994). Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up. Annals of Internal Medicine, 120(4), 287–293.
Rigotti, N. A., Pipe, A. L., Benowitz, N. L., Arteaga, C., Garza, D., & Tonstad, S. (2010). Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial. Circulation, 121(2), 221–229.
Romano, P. S., Bloom, J., & Syme, S. L. (1991). Smoking, social support, and hassles in an urban African-American community. American Journal of Public Health, 81(11), 1415–1422.
Saleh, R., & Shihadeh, A. (2008). Elevated toxicant yields with narghile waterpipes smoked using a plastic hose. Food and Chemical Toxicology, 46(5), 1461–1466.
Samet, J. M. (1991). Health benefits of smoking cessation. Clinics in Chest Medicine, 12(4), 669–679.
Samet, J. M., & Yoon, S. (2001). Women and the tobacco epidemi: Challenges for the 21st century. Geneva: World Health Organization.
Sarna, L., Bialous, S. A., Rice, V. H., & Wewers, M. E. (2009). Promoting tobacco dependence treatment in nursing education. Drug and Alcohol Review, 28(5), 507–516.
Schneider, N. G., & Jarvik, M. E. (1984). Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology (Berlin), 82(1–2), 143–144.
Schneider, N. G., Lunell, E., Olmstead, R. E., & Fagerstrom, K. O. (1996). Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clinical Pharmacokinetics, 31(1), 65–80.
Scott, R. R., & Lamparski, D. (1985). Variables related to long-term smoking status following cardiac events. Addictive Behaviors, 10(3), 257–264.
Sepetdjian, E., Shihadeh, A., & Saliba, N. A. (2008). Measurement of 16 polycyclic aromatic hydrocarbons in narghile waterpipe tobacco smoke. Food And Chemical Toxicology: An International Journal Published For The British Industrial Biological Research Association, 46(5), 1582–1590.
Shiffman, S. (1986). A cluster-analytic classification of relapse episodes. Addictive Behaviors, 11(3), 295–307.
Shiffman, S., & Jarvik, M. E. (1976). Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berlin), 50(1), 35–39.
Shiffman, S., Waters, A., & Hickcox, M. (2004). The nicotine dependence syndrome scale: A multidimensional measure of nicotine dependence. Nicotine & Tobacco Research, 6(2), 327–348.
Shiffman, S., West, R., & Gilbert, D. (2004). Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine & Tobacco Research, 6(4), 599–614.
Shihadeh, A., & Saleh, R. (2005). Polycyclic aromatic hydrocarbons, carbon monoxide, “tar”, and nicotine in the mainstream smoke aerosol of the narghile water pipe. [Research]. Food and Chemical Toxicology, 43, 655–661.
Shishani, K., Nawafleh, H., & Sivarajan Froelicher, E. (2008). Jordanian nurses’ and physicians’ learning needs for promoting smoking cessation. Progress in Cardiovascular Nursing, 23(2), 79–83.
Smith, P. M., Reilly, K. R., Houston Miller, N., DeBusk, R. F., & Taylor, C. B. (2002). Application of a nurse-managed inpatient smoking cessation program. Nicotine & Tobacco Research, 4(2), 211–222.
Solberg, L. I., Boyle, R. G., Davidson, G., Magnan, S. J., & Carlson, C. L. (2001). Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clinic Proceedings, 76(2), 138–143.
Sparrow, D., & Dawber, T. R. (1978). The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. Journal of Chronic Diseases, 31(6–7), 425–432.
Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA, 282(18), 1737–1744.
Stillman, F. A. (1995). Smoking cessation for the hospitalized cardiac patient: Rationale for and report of a model program. The Journal of Cardiovascular Nursing, 9(2), 25–36.
Taylor, C. B., Houston Miller, N., Killen, J. D., & DeBusk, R. F. (1990). Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention. Annals of Internal Medicine, 113(2), 118–123.
Tonstad, S., Farsang, C., Klaene, G., Lewis, K., Manolis, A., Perruchoud, A. P., et al. (2003). Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicentre, randomised study. European Heart Journal, 24(10), 946–955.
Tsoh, J. Y., McClure, J. B., Skaar, K. L., Wetter, D. W., Cinciripini, P. M., Prokhorov, A. V., et al. (1997). Smoking cessation. 2: Components of effective intervention. Behavioral Medicine, 23(1), 15–27.
U. S. Department of Health and Human Services. (1988). The health consequences of smoking: Nicotine addiction. Washington, DC: GPO.
U. S. Department of Health and Human Services. (1996). Treating tobacco use and dependence: Clinical practice guideline. Washington, DC: GPO.
U. S. Department of Health and Human Services. (2000). Treating tobacco use and dependence: Clinical practice guideline. Washington, DC: GPO.
U. S. Department of Health and Human Services. (2008). Treating tobacco use and dependence: Clinical practice guideline, 2008 update. Washington, DC: GPO.
U.S. Department of Health and Human Services. (1983). The health consequences of smoking: Cardiovascular disease. A report of the surgeon general. Rockville: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General.
U.S. Department of Health and Human Services. (2001). Women and smoking: A report of the surgeon general. Rockville: U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General.
U.S. Department of Health and Human Services. (2003). Pathways to freedom: Winning the fight against tobacco. Rockville: Centers for Disease Control and Prevention.
Wack, J. T., & Rodin, J. (1982). Smoking and its effects on body weight and the systems of caloric regulation. The American Journal of Clinical Nutrition, 35(2), 366–380.
Ward, K., Hammal, F., VanderWeg, M., Eissenberg, T., Asfar, T., Rastam, S., et al. (2005). Are waterpipe users interested in quitting? Nicotine & Tobacco Research, 7(1), 149–156.
Welsch, S. K., Smith, S. S., Wetter, D. W., Jorenby, D. E., Fiore, M. C., & Baker, T. B. (1999). Development and validation of the Wisconsin Smoking Withdrawal Scale. Experimental and Clinical Psychopharmacology, 7(4), 354–361.
West, R., & Hajek, P. (2004). Evaluation of the Mood and Physical Symptoms Scale (MPSS) to assess cigarette withdrawal. Psychopharmacology, 177(1–2), 195–199.
Whitlock, E. P., Vogt, T. M., Hollis, J. F., & Lichtenstein, E. (1997). Does gender affect response to a brief clinic-based smoking intervention? American Journal of Preventive Medicine, 13(3), 159–166.
Wilhelmsson, C., Vedin, J. A., Elmfeldt, D., Tibblin, G., & Wilhelmsen, L. (1975). Smoking and myocardial infarction. Lancet, 1(7904), 415–420.
World Health Organization. (2005). Water pipe tobacco smoking: Health effects, research needs and recommended actions by regulations. Geneva: World Health Organization.
Yerger, V. B., Wertz, M., McGruder, C., Froelicher, E. S., & Malone, R. E. (2008). Nicotine replacement therapy: Perceptions of African-American smokers seeking to quit. Journal of the National Medical Association, 100(2), 230–236.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sohn, M., Shishani, K., Okada, A., Froelicher, E.S. (2012). Approaches to Smoking Cessation in a Cardiovascular Population. In: Dornelas, E.A. (eds) Stress Proof the Heart. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5650-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5650-7_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5649-1
Online ISBN: 978-1-4419-5650-7
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)